#ClimateDiary There is no question that #COP28 will be the most important yet. The #GlobalStocktake will be the “biggest accountability moment in history”, and on its basis leaders will need to make crucial key decisions about fiscal and policy commitments. With less than two months to go, we need to all be as well informed as possible and put pressure on leaders as much as we can. I thought I would start a 🧵that I will keep going in the run up 1/n
Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds
A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round.
As Torsten Bell notes, a key problem behind so many issues is a lack of #investment - from the #NHScrisis to #RAAC in #schools, from our #productivity problems, to the state of our #infrastructure; so much would be different if the UK invested at the rate more normal across #Europe.
But notably behind the UK's seeming short-termism is, to me, a wider problem:
in the UK we have just stopped believing in the future... with devastating effects across society!
Venture investments in U.S. life science and biotechnology start-ups in the third quarter of 2023 rose from the previous two quarters to reach pre-pandemic levels.
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K.
A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties.
Why FDI in India is lowest in 16 yrs — no real ease of doing business, ill-considered treaty moves
As percentage of GDP, gross & net FDI are lowest since mid-2000s. ‘Rigidities’ in doing business here, and India’s decision to terminate bilateral treaties are to blame, analysts say.
As artificial intelligence (AI) becomes increasingly integrated into our lives, the concerns surrounding its ethical implications have taken center stage. This article examines these issues.
Life Science Incubator Gains $100M in Start-Up Funds
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant.
The Nasdaq Biotechnology Index, an indicator of investor sentiment in an industry based on science, continued heading down during the third quarter of 2023.
In the ever-evolving world of cryptocurrencies, Stellar (XLM) stands out as a blockchain platform with a mission: to facilitate fast, low-cost cross-border payments and make financial services accessible to everyone, regardless of location or economic status. Founded in 2014 by Jed McCaleb and Joyce Kim, Stellar has gained...
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks.
With a tenth of the population and workforce, they think they are owed half the country’s CPP. This should be a last straw insult. Canada should have its own referendum on kicking Alberta out, land-lock them, stop subsidies and payments, impose its own charges for anything flowing out, sue for all damages from excessive emissions and say good riddance.
The method is: if the #province had not joined #CPP, but instead maintained its own plan (like Quebec), had exactly the same #contributions as it did with CPP, got the same rate of return on #investment as CPP, minus everything paid out of CPP? The reports actually went further and discounted the value of those payouts to get the lower number, even though it's not in the formula.
@cazabon a different interpretation suggests 16% is more realistic, including the potential risks involved. This one doesn’t include trying to take advantage of the rest of Canada.
According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017.
Ethical AI Investment: Balancing Profit and Principles (www.investmentcentralai.com)
As artificial intelligence (AI) becomes increasingly integrated into our lives, the concerns surrounding its ethical implications have taken center stage. This article examines these issues.
Stellar (XLM): Lighting the Way for Cross-Border Payments (www.investmentcentralai.com)
In the ever-evolving world of cryptocurrencies, Stellar (XLM) stands out as a blockchain platform with a mission: to facilitate fast, low-cost cross-border payments and make financial services accessible to everyone, regardless of location or economic status. Founded in 2014 by Jed McCaleb and Joyce Kim, Stellar has gained...